Risk of gallstone disease in advanced chronic phase of fascioliasis: An experimental study in a rat model

Journal of Infectious Diseases

Volumn 188, Issue 5, 2003, Pages 787-793

  Valero, María Adela ^a   Santana, Mercedes ^a   Morales, Maria ^a   Hernandez, Jose Luis ^a   Mas Coma, Santiago ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; BILE DUCT STONE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL INFECTION; FASCIOLA HEPATICA; FASCIOLIASIS; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RISK FACTOR; SNAIL; TREMATODE; WORM EGG;

ANIMALS; CHOLELITHIASIS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FASCIOLA HEPATICA; FASCIOLIASIS; HUMANS; MALE; PREVALENCE; RATS; RATS, WISTAR; RISK FACTORS;

EID: 0141724519     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377281     Document Type: Article

References (61)

1. Mas-Coma S, Bargues MD, Valero MA, Fuentes MV. Adaptation capacities of Fasciola hepatica and their relationships with human fascioliasis: from below sea level up to the very high altitude. In: Combes C, Jourdane J, eds. Taxonomy, ecology and evolution of metazoan parasites. Perpignan, France: Presses Universitaires de Perpignan, 2003:81-123.
2. Mas-Coma S, Bargues MD. Human liver flukes: a review. Res Rev Parasitol 1997; 57:145-218.
3. Chen MG, Mott KE. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 1990; 87:R1-38.
4. Bouree P, Thiebault M. Fasciolose à Fasciola hepatica en Basse Normandie de 1980 à 1990. Bull Soc Fran Parasitol 1993; 11:79-84.
5. Hardman EW, Jones RLH, Davies AH. Fascioliasis: a large outbreak. BMJ 1970; 3:502-5.
6. Apt W, Aguilera X, Vega F, et al. Treatment of human chronic fascioliasis with triclabendazol: drug efficacy and serologic response. Am J Trop Med Hyg 1995; 52:532-5.
7. Arjona R, Riancho JA, Aguado JM, Salesa R, Gonzalez-Macias J. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine (Baltimore) 1995; 74:13-23.
8. Gil-Benito A, Ciolkovitch A, Mas-Coma S, Quilici M. Enquête sur la distomatose à Fasciola hepatica en Corse. Méditerranée Médlcale (Marseille) 1991; 403:21-5.
9. Mas-Coma S, Bargues MD, Esteban JG. Human fasciolosis. In: Dalton JP, ed. Fasciolosis. Wallingford, Oxon, UK: CAB International Publishing, 1999:411-34.
10. Mas-Coma S, Bargues MD, Marty AM, Neafie RC. Hepatic trematodiases. In: Meyers WM, Neafie RC, Marty AM, et al., eds. Pathology of infectious diseases. Vol. 1. Helminthiases. Washington, DC: Armed Forces Institute of Pathology and American Registry of Pathology, 2000:69-92.
11. Esteban JG, Bargues MD, Mas-Coma S. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parasitol 1998; 58:13-42.
12. Mas-Coma S, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 1999; 77:340-6.
13. Rim HJ, Farag HF, Sornmani S, Cross JH. Food-borne trematodes: ignored or emerging? Parasitol Today 1994; 10:207-9.
14. Hopkins DR. Homing in on helminths. Am J Trop Med Hyg 1992; 46:626-34.
15. Hillyer GV, Soler De Galanes M, Rodriguez-Perez J, et al. Use of the falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) and the enzyme-linked immunoelectrotransfer blot (EITB) to determine the prevalence of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 1992; 46:603-9.
16. Mas-Coma S, Angles R, Strauss W, Esteban JG, Oviedo JA, Buchon P. Human fasciolasis in Bolivia: a general analysis and a critical review of existing data. Res Rev Parasitol 1995; 55:73-93.
17. Mas-Coma S, Angles R, Esteban JG, et al. The human fascioliasis high endemic region of the Northern Bolivian Altiplano. Trop Med Int Health 1999; 4:454-67.
18. Bjorland J, Bryan RT, Strauss W, Hillyer GV, Mcauley J.B. An outbreak of acute fascioliasis among Aymara Indians in the Bolivian Altiplano. Clin Infect Dis 1995; 21:1228-33 (erratum: Clin Infect Dis 1996; 23:423).
19. Esteban JG, Flores A, Aguirre C, Strauss W, Angles R, Mas-Coma S. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano. Acta Trop 1997; 66:1-14.
20. Esteban JG, Flores A, Angles R, Strauss W, Aguirre C, Mas-Coma S. A population-based coprological study of human fascioliasis in a hyperendemic area of the Bolivian Altiplano. Trop Med Int Health 1997; 2:695-9.
21. Esteban JG, Flores A, Angles R, Mas-Coma S. High endemicity of human fascioliasis between Lake Titicaca and La Paz valley, Bolivia. Trans R Soc Trop Med Hyg 1999; 93:151-6.
22. O'Neill SM, Parkinson M, Strauss W, Angles R, Dalton JP. Immunodiagnosis of Fasciola hepatica (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. Am J Trop Med Hyg 1998; 58:417-23.
23. Chatterjee KD. Fasciola hepatica. In: Chatterjee KD, ed. Parasitology (protozoology and helminthology). 10th ed. Calcutta: S. N. Guha Ray At Sree Saraswaty Press, 1975:146-8.
24. Dan M, Lichtenstein D, Lavochkin J, Stavorowsky M, Jedwab M, Shibolet S. Human fascioliasis in Israel, an imported case. Isr J Med Sci 1981; 17:430-2.
25. Stemmermann GN. Human infestation with Fasciola gigantica. Am J Pathol 1953; 29:731-53.
26. Grange D, Dhumeaux D, Couzineau P, Bismuth H, Bader JP. Hepatic calcification due to Fasciola gigantica. Arch Surg 1974; 108:113-5.
27. Pina Arroyo J, Garcia Garcia J, Villar Galan JL, Gomez Alonso A. Fasciola hepatica en la vía biliar principal. Rev Esp Enferm Dig 1982; 62:496-501.
28. Wong RK, Peura DA, Mutter ML, Heit HA, Birns MT, Johnson LF. Hemobilia and liver flukes in a patient from Thailand. Gastroenterology 1985; 88:1958-63.
29. Tesana S, Pamarapa A, Sio OT. Acute cholecystitis and Fasciola sp. infection in Thailand: report of two cases. Southeast Asian J Trop Med Public Health 1989; 20:447-52.
30. Cetta F. The role of bacteria in pigment gallstone disease. Ann Surg 1991; 213:315-26.
31. Kodaka T, Mori R, Debari K, Takiguchi R, Higashi S. Backscattered electron imaging and energy-dispersive X-ray microanalysis studies of evidence for calcium salt heterogeneity in fifteen gallstones from an elderly human. Scanning Microsc 1995; 9:907-24.
32. Diehl AK, Schwesinger WH, Holleman DR, Chapman JB, Kurtin WE. Clinical correlates of gallstone composition: distinguishing pigment from cholesterol stone. Am J Gastroenterol 1995; 90:967-72.
33. Tabata M, Nakayama F. Bacteria and gallstones: etiological significance. Digest Dis Sci 1981; 26:218-24.
34. Valero MA, Varea MT, Marin R. Fasciola hepatica: lithogenic capacity in experimentally infested rats and chemical determination of the main stone components. Parasitol Res 2000; 86:558-62.
35. Mas-Coma S, Funatsu IR, Bargues MD. Fasciola hepatica and lymnaeid snails occurring at very high altitude in South America. Parasitology 2001; 123:S115-27.
36. Council of Europe. Council Directive 86/609/EEC. Strasbourg: 24 November 1986.
37. Boray JC. Experimental fascioliasis in Australia. Adv Parasit 1969; 7:95-210.
38. Valero MA, Mas-Coma S. Comparative infectivity of Fasciola hepatica metacercariae from isolates of the main and secondary reservoir animal host species in the Bolivian Altiplano high human endemic region. Folia Parasitol 2000; 47:17-22.
39. Foster JR. A study of the initiation of biliary hyperplasia in rats infected with Fasciola hepatica. Parasitology 1981; 83:253-8.
40. Lopez P, Tuñon MJ, Gonzalez P, Diez N, Bravo AM, Gonzalez-Gallego J. Ductular proliferation and hepatic secretory function in experimental fascioliasis. Exp Parasitol 1993; 77:36-42.
41. Ouviña CB, Pavese A, Lemberg A, Bengochea LA. Liver microsomal phospholipid fatty acids behavior and its relationship to bilirubin UDP-gluconyltransferase activity in bile duct ligated rats. Arch Physiol Biochem 1995; 103:442-4.
42. Swidsinski A, Lee SP. The role of bacteria in gallstone pathogenesis. Front Biosci 2001; 6:E93-103.
43. Leung JW, Yu AS. Hepatolithiasis and biliary parasites. Baillieres Clin Gastroenterol 1997; 11:681-706.
44. Valero MA, Marcos MD, Mas-Coma S. A mathematical model for the ontogeny of Fasciola hepatica in the definitive host. Res Rev Parasitol 1996; 56:13-20.
45. Valero MA, Marcos MD, Fons R, Mas-Coma S. Fasciola hepatica development in experimentally infected black rat, Rattus rattus. Parasitol Res 1998; 84:188-94.
46. Valero MA, Darce NA, Panova M, Mas-Coma S. Relationships between host species and morphometric patterns in Fasciola hepatica adults and eggs from the Northern Bolivian Altiplano hyperendemic region. Vet Parasitol 2001; 102:85-100.
47. Cosme A, Marcos JM, Galvany A, et al. Choledochal obstruction due to Fasciola hepatica [in Spanish]. Med Clín (Barc) 1979; 73:438-42.
48. Bendezu P, Frame A, Hillyer GV. Human fascioliasis in Corozal, Puerto Rico. J Parasitol 1982; 68:297-9.
49. Knobloch J, Delgado AE, Alvarez GA, Reymann U, Bialek R. Human fascioliasis in Cajamarca/Perú. I. Diagnostic methods and treatment with praziquantel. Trop Med Parasitol 1985; 36:88-90.
50. Akahane H, Oshima T, Shimazu T, Hirosawa K. Diagnosis of fascioliasis. I. Comparison of the efficacies of various concentration techniques of ova in stool [in Japanese]. Jpn J Parasit 1975; 24:55-60.
51. Esteban JG, Gonzalez C, Bargues MD, et al. High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 2002; 7:339-48.
52. Scragg RKR, Calvert GD, Oliver JR. Plasma lipid and insulin in gallstone disease: a case control study. BMJ 1984; 289:521-5.
53. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99:843-9.
54. Bell GD, Lewis B, Petrie A, Dowling RH. Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. BMJ 1973; 3:520-3.
55. Soloway RD, Trotman BW, Ostrow JD. Pigment gallstones. Gastroenterology, 1977; 72:167-82.
56. Thorpe E. Liver damage and the host-parasite relationship in experimental fascioliasis in the albino rat. Res Vet Sci 1965; 6:498-509.
57. Leathers CW, Foreyt WJ, Fetcher A, Foreyt KM. Clinical fascioliasis in domestic goats in Montana. J Am Vet Med Assoc 1982; 180:1451-4.
58. Cornick JL. Gastric squamous cell carcinoma and fascioliasis in a llama. Cornell Vet 1988; 78:235-41.
59. Cosme A, Ojeda E, Cilla G, et al. Fasciola hepatica, study of a series of 37 patients. Gastroenterol Hepatol 2001; 24:375-80.
60. De Gorgolas M, Torres R, Verdejo C, et al. Fasciola hepatica infestation: biopathology, and new diagnostic aspects. Enferm Infecc Microbiol Clín 1992; 10:514-9.
61. Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci 1992; 37:912-8.